Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional American Depositary Shares - Structure Therapeutics (NASDAQ:GPCR)

SAN FRANCISCO, June 07, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ:GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and

Related Keywords

New York ,United States ,Boston ,Massachusetts ,American ,Danielle Keatley ,Exchange Commission ,Syndicate Department ,Equity Syndicate Prospectus Department ,Morgan Stanley ,Goldman Sachs Co ,Equity Syndicate Department ,Morgan Stanley Co ,Prospectus Department ,Structure Therapeutics Inc ,Capital Markets Corp ,Guggenheim Securities ,Structure Therapeutics ,Leerink Partners ,Markets Corp ,